Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02833246 · ClinicalTrials.gov registry record · NA
Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications
A NA study of Sarcoma and Lung, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT02833246: Completed NA study of Sarcoma and Lung, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02833246 is a NA study of Sarcoma and Lung that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 28 participants, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02833246, a NA study of Sarcoma and Lung, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.
Primary Outcome
is greater or less than the amount of OAM that the patient should have in their possession.
Conditions Studied
Interventions
- OTHER usual care
- OTHER SMS/MMS text messaging
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2016-06-28 |
| Est. Completion | 2018-11-14 |
| Phase | NA |
What the finished NCT02833246 record still lists
NCT02833246 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Sarcoma appearing as the primary indexed condition, and to 2 interventions - of which usual care is the first listed.
NCT02833246 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02833246 about?
NCT02833246 is a clinical study titled "Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications". This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.
What is the current status of trial NCT02833246?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2016-06-28. Estimated completion is 2018-11-14.
What conditions does trial NCT02833246 study?
This clinical trial studies the following conditions: Sarcoma, Lung, Solid Tumor Gastrointestinal.
What interventions are being tested in trial NCT02833246?
The interventions under investigation include: usual care (OTHER), SMS/MMS text messaging (OTHER).
Who is sponsoring clinical trial NCT02833246?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02833246 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02833246's enrollment target sits among peer trials
28 94th of 122 higher than 28 of 122 other Sarcoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sarcoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
Enhanced Recovery After Surgery in Extremity Sarcoma
RECRUITING · NA
-
Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patients
RECRUITING · NA
-
A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma
RECRUITING · NA
-
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
RECRUITING · NA
-
GRID Therapy for Extremity Soft Tissue Sarcoma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy